TY - JOUR AU - Gruntzig, A. PY - 1978 DA - 1978// TI - Transluminal dilatation of coronary-artery stenosis JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(78)90500-7 DO - 10.1016/S0140-6736(78)90500-7 ID - Gruntzig1978 ER - TY - JOUR AU - Farooq, V. AU - Gogas, B. D. AU - Serruys, P. W. PY - 2011 DA - 2011// TI - Restenosis: delineating the numerous causes of drug-eluting stent restenosis JO - Circ Cardiovasc Interv VL - 4 UR - https://doi.org/10.1161/CIRCINTERVENTIONS.110.959882 DO - 10.1161/CIRCINTERVENTIONS.110.959882 ID - Farooq2011 ER - TY - JOUR AU - Gruntzig, A. R. AU - Senning, A. AU - Siegenthaler, W. E. PY - 1979 DA - 1979// TI - Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty JO - N Engl J Med VL - 301 UR - https://doi.org/10.1056/NEJM197907123010201 DO - 10.1056/NEJM197907123010201 ID - Gruntzig1979 ER - TY - JOUR AU - Sigwart, U. AU - Urban, P. AU - Golf, S. AU - Kaufmann, U. AU - Imbert, C. AU - Fischer, A. PY - 1988 DA - 1988// TI - Emergency stenting for acute occlusion after coronary balloon angioplasty JO - Circulation VL - 78 UR - https://doi.org/10.1161/01.CIR.78.5.1121 DO - 10.1161/01.CIR.78.5.1121 ID - Sigwart1988 ER - TY - JOUR AU - Roubin, G. S. AU - Cannon, A. D. AU - Agrawal, S. K. AU - Macander, P. J. AU - Dean, L. S. AU - Baxley, W. A. PY - 1992 DA - 1992// TI - Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty JO - Circulation VL - 85 UR - https://doi.org/10.1161/01.CIR.85.3.916 DO - 10.1161/01.CIR.85.3.916 ID - Roubin1992 ER - TY - JOUR AU - Serruys, P. W. AU - Strauss, B. H. AU - Beatt, K. J. AU - Bertrand, M. E. AU - Puel, J. AU - Rickards, A. F. PY - 1991 DA - 1991// TI - Angiographic follow-up after placement of a self-expanding coronary-artery stent JO - N Engl J Med VL - 324 UR - https://doi.org/10.1056/NEJM199101033240103 DO - 10.1056/NEJM199101033240103 ID - Serruys1991 ER - TY - JOUR AU - Serruys, P. W. AU - Jaegere, P. AU - Kiemeneij, F. AU - Macaya, C. AU - Rutsch, W. AU - Heyndrickx, G. PY - 1994 DA - 1994// TI - A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group JO - N Engl J Med VL - 331 UR - https://doi.org/10.1056/NEJM199408253310801 DO - 10.1056/NEJM199408253310801 ID - Serruys1994 ER - TY - JOUR AU - Fischman, D. L. AU - Leon, M. B. AU - Baim, D. S. AU - Schatz, R. A. AU - Savage, M. P. AU - Penn, I. PY - 1994 DA - 1994// TI - A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators JO - N Engl J Med VL - 331 UR - https://doi.org/10.1056/NEJM199408253310802 DO - 10.1056/NEJM199408253310802 ID - Fischman1994 ER - TY - JOUR AU - Hoffmann, R. AU - Mintz, G. S. AU - Dussaillant, G. R. AU - Popma, J. J. AU - Pichard, A. D. AU - Satler, L. F. PY - 1996 DA - 1996// TI - Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study JO - Circulation VL - 94 UR - https://doi.org/10.1161/01.CIR.94.6.1247 DO - 10.1161/01.CIR.94.6.1247 ID - Hoffmann1996 ER - TY - JOUR AU - Gordon, P. C. AU - Gibson, C. M. AU - Cohen, D. J. AU - Carrozza, J. P. AU - Kuntz, R. E. AU - Baim, D. S. PY - 1993 DA - 1993// TI - Mechanisms of restenosis and redilation within coronary stents—quantitative angiographic assessment JO - J Am Coll Cardiol VL - 21 UR - https://doi.org/10.1016/0735-1097(93)90241-R DO - 10.1016/0735-1097(93)90241-R ID - Gordon1993 ER - TY - JOUR AU - Karas, S. P. AU - Gravanis, M. B. AU - Santoian, E. C. AU - Robinson, K. A. AU - Anderberg, K. A. AU - King, S. B. PY - 1992 DA - 1992// TI - Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis JO - J Am Coll Cardiol VL - 20 UR - https://doi.org/10.1016/0735-1097(92)90119-8 DO - 10.1016/0735-1097(92)90119-8 ID - Karas1992 ER - TY - JOUR AU - Dussaillant, G. R. AU - Mintz, G. S. AU - Pichard, A. D. AU - Kent, K. M. AU - Satler, L. F. AU - Popma, J. J. PY - 1995 DA - 1995// TI - Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis JO - J Am Coll Cardiol VL - 26 UR - https://doi.org/10.1016/0735-1097(95)00249-4 DO - 10.1016/0735-1097(95)00249-4 ID - Dussaillant1995 ER - TY - JOUR AU - Sousa, J. E. AU - Costa, M. A. AU - Abizaid, A. C. AU - Rensing, B. J. AU - Abizaid, A. S. AU - Tanajura, L. F. PY - 2001 DA - 2001// TI - Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascularultrasound follow-up JO - Circulation VL - 104 UR - https://doi.org/10.1161/hc4201.098056 DO - 10.1161/hc4201.098056 ID - Sousa2001 ER - TY - JOUR AU - Stone, G. W. AU - Ellis, S. G. AU - Cox, D. A. AU - Hermiller, J. AU - O'Shaughnessy, C. AU - Mann, J. T. PY - 2004 DA - 2004// TI - A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa032441 DO - 10.1056/NEJMoa032441 ID - Stone2004 ER - TY - JOUR AU - Daemen, J. AU - Wenaweser, P. AU - Tsuchida, K. AU - Abrecht, L. AU - Vaina, S. AU - Morger, C. PY - 2007 DA - 2007// TI - Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study JO - Lancet VL - 369 UR - https://doi.org/10.1016/S0140-6736(07)60314-6 DO - 10.1016/S0140-6736(07)60314-6 ID - Daemen2007 ER - TY - JOUR AU - Wenaweser, P. AU - Daemen, J. AU - Zwahlen, M. AU - Domburg, R. AU - Juni, P. AU - Vaina, S. PY - 2008 DA - 2008// TI - Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study JO - J Am Coll Cardiol VL - 52 UR - https://doi.org/10.1016/j.jacc.2008.07.006 DO - 10.1016/j.jacc.2008.07.006 ID - Wenaweser2008 ER - TY - JOUR AU - Virmani, R. AU - Guagliumi, G. AU - Farb, A. AU - Musumeci, G. AU - Grieco, N. AU - Motta, T. PY - 2004 DA - 2004// TI - Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? JO - Circulation VL - 109 UR - https://doi.org/10.1161/01.CIR.0000116202.41966.D4 DO - 10.1161/01.CIR.0000116202.41966.D4 ID - Virmani2004 ER - TY - JOUR AU - Serruys, P. W. AU - Onuma, Y. AU - Garg, S. AU - Vranckx, P. AU - Bruyne, B. AU - Morice, M. C. PY - 2010 DA - 2010// TI - ARTS II Investigators. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions JO - J Am Coll Cardiol VL - 55 UR - https://doi.org/10.1016/j.jacc.2009.11.049 DO - 10.1016/j.jacc.2009.11.049 ID - Serruys2010 ER - TY - JOUR AU - Hofma, S. H. AU - Giessen, W. J. AU - Dalen, B. M. AU - Lemos, P. A. AU - McFadden, E. P. AU - Sianos, G. PY - 2006 DA - 2006// TI - Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation JO - Eur Heart J VL - 27 UR - https://doi.org/10.1093/eurheartj/ehi571 DO - 10.1093/eurheartj/ehi571 ID - Hofma2006 ER - TY - JOUR AU - Togni, M. AU - Windecker, S. AU - Cocchia, R. AU - Wenaweser, P. AU - Cook, S. AU - Billinger, M. PY - 2005 DA - 2005// TI - Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction JO - J Am Coll Cardiol VL - 46 UR - https://doi.org/10.1016/j.jacc.2005.01.062 DO - 10.1016/j.jacc.2005.01.062 ID - Togni2005 ER - TY - BOOK AU - Shalaby, S. W. AU - Burg, K. J. L. PY - 2003 DA - 2003// TI - Absorbable and Biodegradable Polymers (Advances in Polymeric Biomaterials) PB - CRC Press CY - Boca Raton, FL UR - https://doi.org/10.1201/9780203493014 DO - 10.1201/9780203493014 ID - Shalaby2003 ER - TY - JOUR AU - Ormiston, J. A. AU - Serruys, P. W. AU - Regar, E. AU - Dudek, D. AU - Thuesen, L. AU - Webster, M. W. PY - 2008 DA - 2008// TI - A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60415-8 DO - 10.1016/S0140-6736(08)60415-8 ID - Ormiston2008 ER - TY - JOUR AU - Heublein, B. AU - Rohde, R. AU - Kaese, V. AU - Niemeyer, M. AU - Hartung, W. AU - Haverich, A. PY - 2003 DA - 2003// TI - Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? JO - Heart VL - 89 UR - https://doi.org/10.1136/heart.89.6.651 DO - 10.1136/heart.89.6.651 ID - Heublein2003 ER - TY - JOUR AU - Waksman, R. AU - Pakala, R. AU - Kuchulakanti, P. K. AU - Baffour, R. AU - Hellinga, D. AU - Seabron, R. PY - 2006 DA - 2006// TI - Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries JO - Catheter Cardiovasc Interv VL - 68 UR - https://doi.org/10.1002/ccd.20727 DO - 10.1002/ccd.20727 ID - Waksman2006 ER - TY - STD TI - Università degli Studi di PaviaStructural Mechanics Department. http://www.dist.unina.it/doc/seminari/corso_Auricchio/biomaterials.pdf. Accessed 04 March 2015 UR - http://www.dist.unina.it/doc/seminari/corso_Auricchio/biomaterials.pdf ID - ref25 ER - TY - JOUR AU - Brugaletta, S. AU - Radu, M. D. AU - Garcia-Garcia, H. M. AU - Heo, J. H. AU - Farooq, V. AU - Girasis, C. PY - 2012 DA - 2012// TI - Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque? JO - Atherosclerosis VL - 221 UR - https://doi.org/10.1016/j.atherosclerosis.2011.12.008 DO - 10.1016/j.atherosclerosis.2011.12.008 ID - Brugaletta2012 ER - TY - JOUR AU - Joner, M. AU - Finn, A. V. AU - Farb, A. AU - Mont, E. K. AU - Kolodgie, F. D. AU - Ladich, E. PY - 2006 DA - 2006// TI - Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk JO - J Am Coll Cardiol VL - 48 UR - https://doi.org/10.1016/j.jacc.2006.03.042 DO - 10.1016/j.jacc.2006.03.042 ID - Joner2006 ER - TY - JOUR AU - Onuma, Y. AU - Serruys, P. W. AU - Perkins, L. E. AU - Okamura, T. AU - Gonzalo, N. AU - García-García, H. M. PY - 2010 DA - 2010// TI - Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial JO - Circulation VL - 122 UR - https://doi.org/10.1161/CIRCULATIONAHA.109.921528 DO - 10.1161/CIRCULATIONAHA.109.921528 ID - Onuma2010 ER - TY - JOUR AU - Garg, S. AU - Serruys, P. AU - Onuma, Y. AU - Dorange, C. AU - Veldhof, S. AU - Miquel-Hébert, K. PY - 2009 DA - 2009// TI - 3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions) JO - JACC Cardiovasc Interv VL - 2 UR - https://doi.org/10.1016/j.jcin.2009.10.002 DO - 10.1016/j.jcin.2009.10.002 ID - Garg2009 ER - TY - JOUR AU - Verheye, S. AU - Ormiston, J. A. AU - Stewart, J. AU - Webster, M. AU - Sanidas, E. AU - Costa, R. PY - 2014 DA - 2014// TI - A next-generation bioresorbable coronary scaffold system-from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results JO - J Am Coll Cardiol Intv VL - 7 UR - https://doi.org/10.1016/j.jcin.2013.07.007 DO - 10.1016/j.jcin.2013.07.007 ID - Verheye2014 ER - TY - JOUR AU - Brugaletta, S. AU - Heo, J. H. AU - Garcia-Garcia, H. M. AU - Farooq, V. AU - Geuns, R. J. AU - Bruyne, B. PY - 2012 DA - 2012// TI - Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy JO - Eur Heart J VL - 33 UR - https://doi.org/10.1093/eurheartj/ehr466 DO - 10.1093/eurheartj/ehr466 ID - Brugaletta2012 ER - TY - JOUR AU - Erbel, R. AU - Mario, C. AU - Bartunek, J. AU - Bonnier, J. AU - Bruyne, B. AU - Eberli, F. R. PY - 2007 DA - 2007// TI - Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: A prospective, non-randomised multicentre trial JO - Lancet VL - 369 UR - https://doi.org/10.1016/S0140-6736(07)60853-8 DO - 10.1016/S0140-6736(07)60853-8 ID - Erbel2007 ER - TY - JOUR AU - Barlis, P. AU - Tanigawa, J. AU - Mario, C. PY - 2007 DA - 2007// TI - Coronary bioabsorbable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings JO - Eur Heart J VL - 28 UR - https://doi.org/10.1093/eurheartj/ehm119 DO - 10.1093/eurheartj/ehm119 ID - Barlis2007 ER - TY - JOUR AU - Ghimire, G. AU - Spiro, J. AU - Kharbanda, R. AU - Roughton, M. AU - Barlis, P. AU - Mason, M. PY - 2009 DA - 2009// TI - Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents JO - EuroIntervention VL - 4 UR - https://doi.org/10.4244/JV4I4A82 DO - 10.4244/JV4I4A82 ID - Ghimire2009 ER - TY - JOUR AU - Haude, M. AU - Erbel, R. AU - Erne, P. AU - Verheye, S. AU - Degen, H. AU - Böse, D. PY - 2013 DA - 2013// TI - Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)61765-6 DO - 10.1016/S0140-6736(12)61765-6 ID - Haude2013 ER - TY - JOUR AU - Tamai, H. AU - Igaki, K. AU - Kyo, E. AU - Kosuga, K. AU - Kawashima, A. AU - Matsui, S. PY - 2000 DA - 2000// TI - Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans JO - Circulation VL - 102 UR - https://doi.org/10.1161/01.CIR.102.4.399 DO - 10.1161/01.CIR.102.4.399 ID - Tamai2000 ER - TY - JOUR AU - Tsuji, T. AU - Tamai, H. AU - Igaki, K. AU - Hsu, Y. -. S. AU - Kosuga, K. AU - Hata, T. PY - 2004 DA - 2004// TI - Four-year follow-up of the biodegradable stent (Igaki-Tamai stent) JO - Circ J VL - 68 UR - https://doi.org/10.1253/circj.68.135 DO - 10.1253/circj.68.135 ID - Tsuji2004 ER - TY - JOUR AU - Nishio, S. PY - 2010 DA - 2010// TI - Long-term (>10 years) clinical outcomes of first-in-man biodegradable poly-l-lactic acid coronary stents JO - Eurointervenion VL - 6 UR - https://doi.org/10.4244/EIJV6SUPJA8 DO - 10.4244/EIJV6SUPJA8 ID - Nishio2010 ER - TY - JOUR AU - Biamino, G. AU - Schmidt, A. AU - Scheinert, D. PY - 2005 DA - 2005// TI - Treatment of SFA lesions with PLLA biodegradable stents: results of the PERSEUS Study JO - J Endovasc Ther VL - 12 ID - Biamino2005 ER - TY - STD TI - Schulze R. REVA Medical, Inc. Bioresorbable stent. In: Cardiovascular Revascularization Therapies 2007. ID - ref40 ER - TY - STD TI - Grube E. Bioabsorbable stent: the Boston Scientific and REVA technology. Presented at: EuroPCR; May 19–22, 2009; Barcelona, Spain. ID - ref41 ER - TY - STD TI - Costa RA. REVA ReZolve clinical program update. In: Transcatheter Cardiovascular Therapeutics, Miami Beach, FL, 2012. ID - ref42 ER - TY - STD TI - ReZolve2 Clinical Investigation (RESTORE II). www.clinicaltrials.gov. Accessed 20 Feb 2015 UR - http://www.clinicaltrials.gov ID - ref43 ER - TY - STD TI - Abizaid A. Cardiovascular Research Technologies (CRT) 2015. ID - ref44 ER - TY - JOUR AU - Jabara, R. AU - Chronos, N. AU - Robinson, K. PY - 2008 DA - 2008// TI - Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating JO - Catheter Cardiovasc Interv VL - 72 UR - https://doi.org/10.1002/ccd.21607 DO - 10.1002/ccd.21607 ID - Jabara2008 ER - TY - JOUR AU - Jabara, R. AU - Pendyala, L. AU - Geva, S. AU - Chen, J. AU - Chronos, N. AU - Robinson, K. PY - 2009 DA - 2009// TI - Novel fully bioabsorbable salicylate-based sirolimus-eluting stent JO - EuroIntervention VL - 5 UR - https://doi.org/10.4244/EIJV5IFA10 DO - 10.4244/EIJV5IFA10 ID - Jabara2009 ER - TY - STD TI - Verheye S. First-in-man results with a myolimus-eluting bioresorbable PLLA-based vascular scaffold.Presented in Transcatheter Cardiovasc Therapeutics. Miami Beach , FL; October 23rd 2012.USA. ID - ref47 ER - TY - STD TI - 48:Verheye S. DESolve Nx Novolimus-Eluting PLLA-Based BRS: First Report of the 6-month OCT and 12-month Clinical and Imaging Result. Presented in Transcatheter Cardiovasc Therapeutics. San Fransisco, CA, USA; October 27th 2013. ID - ref48 ER - TY - STD TI - Abizaid A. Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results. Presented in Transcatheter Cardiovasc Therapeutics. Washington, DC. USA; September 16th 2014. ID - ref49 ER - TY - JOUR AU - Serruys, P. W. AU - Ormiston, J. A. AU - Onuma, Y. AU - Regar, E. AU - Gonzalo, N. AU - Garcia-Garcia, H. M. PY - 2009 DA - 2009// TI - A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60325-1 DO - 10.1016/S0140-6736(09)60325-1 ID - Serruys2009 ER - TY - JOUR AU - Onuma, Y. AU - Serruys, P. AU - Ormiston, J. AU - Regar, E. AU - Webster, M. AU - Thuesen, L. PY - 2010 DA - 2010// TI - Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: The ABSORB trial JO - EuroIntervention VL - 6 UR - https://doi.org/10.4244/EIJ30V6I4A76 DO - 10.4244/EIJ30V6I4A76 ID - Onuma2010 ER - TY - JOUR AU - Tanimoto, S. AU - Serruys, P. W. AU - Thuesen, L. AU - Dudek, D. AU - Bruyne, B. AU - Chevalier, B. PY - 2007 DA - 2007// TI - Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus- eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT Trials JO - Cathet Cardiovasc Interv VL - 70 UR - https://doi.org/10.1002/ccd.21136 DO - 10.1002/ccd.21136 ID - Tanimoto2007 ER - TY - JOUR AU - Garg, S. AU - Serruys, P. PY - 2009 DA - 2009// TI - Biodegradable stents and nonbiodegradable stents JO - Minerva Cardioangiol VL - 57 ID - Garg2009 ER - TY - JOUR AU - Ormiston, J. A. AU - Serruys, P. W. AU - Onuma, Y. AU - Geuns, R. J. AU - Bruyne, B. AU - Dudek, D. PY - 2012 DA - 2012// TI - First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study JO - Circ Cardiovasc Interv VL - 5 UR - https://doi.org/10.1161/CIRCINTERVENTIONS.112.971549 DO - 10.1161/CIRCINTERVENTIONS.112.971549 ID - Ormiston2012 ER - TY - JOUR AU - Serruys, P. W. AU - Onuma, Y. AU - Dudek, D. AU - Smits, P. C. AU - Koolen, J. AU - Chevalier, B. PY - 2011 DA - 2011// TI - Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes JO - J Am Coll Cardiol VL - 58 UR - https://doi.org/10.1016/j.jacc.2011.05.050 DO - 10.1016/j.jacc.2011.05.050 ID - Serruys2011 ER - TY - JOUR AU - Serruys, P. W. AU - Onuma, Y. AU - Garcia-Garcia, H. M. AU - Muramatsu, T. AU - Geuns, R. J. AU - Bruyne, B. PY - 2014 DA - 2014// TI - Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months JO - EuroIntervention VL - 9 UR - https://doi.org/10.4244/EIJV9I11A217 DO - 10.4244/EIJV9I11A217 ID - Serruys2014 ER - TY - JOUR AU - Serruys, P. W. AU - Chevalier, B. AU - Dudek, D. AU - Cequier, A. AU - Carrie, D. AU - Iniguez, A. PY - 2015 DA - 2015// TI - A bioresorbable everolimus-eluting scaff old versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)61455-0 DO - 10.1016/S0140-6736(14)61455-0 ID - Serruys2015 ER - TY - JOUR AU - Dudek, D. AU - Rzeszutko, Ł. AU - Zasada, W. AU - Depukat, R. AU - Siudak, Z. AU - Ochała, A. PY - 2014 DA - 2014// TI - Bioresorbable vascular scaffolds in patients with acute coronary syndromes : the POLAR ACS study JO - Pol Arch Med Wewn VL - 124 ID - Dudek2014 ER - TY - JOUR AU - Lafont, A. AU - Durand, E. PY - 2009 DA - 2009// TI - A.R.T. concept of a bioresorbable stent without drug elution JO - EuroIntervention VL - 5 UR - https://doi.org/10.4244/EIJV5IFA14 DO - 10.4244/EIJV5IFA14 ID - Lafont2009 ER - TY - JOUR AU - Durand, E. AU - Lemitre, M. AU - Couty, L. AU - Sharkawi, T. AU - Brasselet, C. AU - Vert, M. PY - 2012 DA - 2012// TI - Adjusting a polymer formulation for an optimal bioresorbable stent: a 6-month follow-up study JO - EuroIntervention VL - 8 UR - https://doi.org/10.4244/EIJV8I2A38 DO - 10.4244/EIJV8I2A38 ID - Durand2012 ER - TY - STD TI - Fajadet J. The ART, stent: design and early first-in-man experiences.Presented in Transcatheter Cardiovasc Therapeutics. Miami Beach , FL, USA; October 23rd 2012. ID - ref61 ER - TY - STD TI - Lafont A. ARTDIVA. Presented in BRS 2014. Boston, MA, USA; July 6th 2014. ID - ref62 ER - TY - JOUR AU - Shen, L. AU - Wang, Q. AU - Wu, Y. AU - Xie, J. AU - Zhang, F. AU - Ge, L. PY - 2009 DA - 2009// TI - Preliminary evaluation of fully bioabsorbable PLLA sirolimus eluting stents in a porcine model JO - Chin J Intervent Cardiol VL - 19 ID - Shen2009 ER - TY - STD TI - Shen L, Wang Q, Wu Y, Xie J, Ge J. Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary stents in a porcine model. Transcatheter Cardiovasc Ther 2011 ID - ref64 ER - TY - STD TI - 65:Wu Y, Shen L, Yao Z, Ge L, Wang Q, Qian J, et al. Long-term Angiographic and Optical Coherence Tomography Follow-up of XINSORB Scaffold in Porcine Coronary Model.Abstract presentation in Transcatheter Cardiovasc Therapeutics 2014. Washington, DC. USA; September 13-17 2014. ID - ref65 ER - TY - STD TI - Ge J. BRS Under Development III – The XINSORB BRS. Presented in Transcatheter Cardiovasc Therapeutics. Washington, DC. USA; September 16th 2014. ID - ref66 ER - TY - STD TI - Santoso T. The Mirage Bioresorbable Microfiber Scaffold (BRMS) Manli Cardiology. Presented in Transcatheter Cardiovasc Therapeutics. Washington, DC. USA; September 16th 2014. ID - ref67 ER - TY - JOUR AU - Windecker, S. AU - Kolh, P. AU - Alfonso, F. AU - Collet, J. P. AU - Cremer, J. AU - Falk, V. PY - 2015 DA - 2015// TI - 2014 ESC/EACTS guidelines on myocardial revascularization JO - EuroIntervention VL - 10 UR - https://doi.org/10.4244/EIJY14M09_01 DO - 10.4244/EIJY14M09_01 ID - Windecker2015 ER - TY - JOUR AU - Mitsutake, Y. AU - Ueno, T. AU - Ikeno, F. AU - Yokoyama, S. AU - Sasaki, K. AU - Ohtsuka, M. PY - 2015 DA - 2015// TI - Second-generation everolimus-eluting stents demonstrate better vascular function, less thrombus formation, and less yellow intima than first-generation drug-eluting stents JO - AsiaIntervention VL - 1 ID - Mitsutake2015 ER - TY - JOUR AU - Serruys, P. W. PY - 2014 DA - 2014// TI - Innovations: resetting our thinking to solve problems JO - EuroIntervention VL - 10 UR - https://doi.org/10.4244/EIJV10I4A71 DO - 10.4244/EIJV10I4A71 ID - Serruys2014 ER -